Literature DB >> 25054448

Laparoscopic and open abdominal staging for early-stage ovarian cancer: our experience, systematic review, and meta-analysis of comparative studies.

Giorgio Bogani1, Antonella Cromi, Maurizio Serati, Edoardo Di Naro, Jvan Casarin, Ciro Pinelli, Fabio Ghezzi.   

Abstract

OBJECTIVES: The aim of this study was to analyze perioperative and long-term survival outcomes after either laparoscopic or open abdominal staging for apparent early-stage ovarian cancer.
METHODS: Data of consecutive women with early-stage ovarian cancer undergoing comprehensive laparoscopic staging between 2003 and 2010 were matched with a historical cohort of patients undergoing open surgery. Five-year survival outcomes were analyzed using the Kaplan-Meier method. In addition, a systematic review of the literature and meta-analysis of comparative studies was performed
RESULTS: A total of 35 women undergoing staging via laparoscopy were compared with a cohort of 32 patients undergoing open surgery. Baseline characteristics were similar between groups. Spillage occurred in 6 and 4 patients in laparoscopic and open group, respectively (P = 0.59). Patients undergoing laparoscopy experienced longer operative time (P < 0.001), shorter hospital stay (P = 0.03), and lower postoperative complication rate (3% vs 28%; P = 0.005) than patients undergoing staging via open surgery. The median (range) follow-up period was 64 (37-106) and 100 (61-278) months for case and control, respectively (P < 0.001). Five-year disease-free survival (P = 0.12, log-rank test) and overall survival (P = 0.26, log-rank test) were not influenced by surgical approach. Pooled analyses of the literature results corroborate our results suggesting an improvement of perioperative results in the laparoscopic group in comparison with the open abdominal one. In comparison with open surgery, laparoscopy did not influenced spillage (odds ratio [OR], 0.78; 95% confidence interval [CI], 0.35-1.73) and upstaging rate (OR, 0.7; 95% CI, 0.38-1.27). No between-group differences in survival were observed (OR, 0.5; 95% CI, 0.21-1.21).
CONCLUSIONS: Laparoscopy upholds open surgery in long-term oncologic control, reducing morbidity.

Entities:  

Mesh:

Year:  2014        PMID: 25054448     DOI: 10.1097/IGC.0000000000000214

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  11 in total

1.  Minimally invasive surgery for early-stage ovarian cancer: Association between hospital surgical volume and short-term perioperative outcomes.

Authors:  Koji Matsuo; Erica J Chang; Shinya Matsuzaki; Rachel S Mandelbaum; Kazuhide Matsushima; Brendan H Grubbs; Maximilian Klar; Lynda D Roman; Anil K Sood; Jason D Wright
Journal:  Gynecol Oncol       Date:  2020-05-10       Impact factor: 5.482

2.  Current and Future Status of Laparoscopy in Gynecologic Oncology.

Authors:  S Rimbach; K Neis; E Solomayer; U Ulrich; D Wallwiener
Journal:  Geburtshilfe Frauenheilkd       Date:  2014-09       Impact factor: 2.915

3.  Clinical value of combining transvaginal contrast-enhanced ultrasonography with serum human epididymisprotein-4 and the resistance index for early-stage epithelial ovarian cancer.

Authors:  Wu Meng; Wang Ying; Zheng Qichao; Li Ping; Tang Jie
Journal:  Saudi Med J       Date:  2017-06       Impact factor: 1.484

Review 4.  Is It the Time for Laparoscopic Management of Early-stage Ovarian Malignancies?

Authors:  Tanitra Tantitamit; Chyi-Long Lee
Journal:  Gynecol Minim Invasive Ther       Date:  2018-08-23

5.  Minimally invasive surgery techniques in pelvic exenteration: a systematic and meta-analysis review.

Authors: 
Journal:  Surg Endosc       Date:  2018-07-17       Impact factor: 4.584

Review 6.  Laparoscopy versus laparotomy for FIGO stage I ovarian cancer.

Authors:  Frederico S Falcetta; Theresa A Lawrie; Lídia Rf Medeiros; Maria Ines da Rosa; Maria I Edelweiss; Airton T Stein; Alice Zelmanowicz; Anaelena B Moraes; Roselaine R Zanini; Daniela D Rosa
Journal:  Cochrane Database Syst Rev       Date:  2016-10-13

7.  The Role of Minimally Invasive Surgery in the Care of Women with Ovarian Cancer: A Systematic Review and Meta-analysis.

Authors:  Anne Knisely; Charlotte R Gamble; Caryn M St Clair; June Y Hou; Fady Khoury-Collado; Allison A Gockley; Jason D Wright; Alexander Melamed
Journal:  J Minim Invasive Gynecol       Date:  2020-11-14       Impact factor: 4.314

8.  Determination of reference intervals of serum levels of human epididymis protein 4 (HE4) in Chinese women.

Authors:  Yaping Tian; Chuanxin Wang; Liming Cheng; Aimin Zhang; Wen Liu; Lin Guo; Huiming Ye; Yanchun Huang; Jing Chen; Xinyu Wen; Yuelei Xing; Guixi Zheng; Ziyong Sun; Huijun Li; Peng Zhang; Wanli Liu; Ying Chen; Zhongying Zhang; Yi Xu; Yishan Huo; Qishui Ou
Journal:  J Ovarian Res       Date:  2015-11-09       Impact factor: 4.234

9.  Recurrent peritoneal serous carcinoma that was unmanageable with paclitaxel-carboplatin therapy responded to autologous formalin-fixed tumor vaccine.

Authors:  Jui-Tung Chen; Tadao Ohno
Journal:  Clin Case Rep       Date:  2015-09-02

10.  Ovarian cancer surgery in Germany: An analysis of the nationwide hospital file 2005-2015.

Authors:  Pietro Trocchi; Pawel Mach; Karl Rainer Kimmig; Andreas Stang
Journal:  Womens Health (Lond)       Date:  2022 Jan-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.